Parkside Financial Bank & Trust’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$15.1K Sell
1,267
-5
-0.4% -$51 ﹤0.01% 1425
2025
Q4
$12.7K Sell
1,272
-101
-7% -$965 ﹤0.01% 1478
2025
Q3
$12.3K Sell
1,373
-7
-0.5% -$65 ﹤0.01% 1438
2025
Q2
$13K Buy
1,380
+559
+68% +$4.93K ﹤0.01% 1406
2025
Q1
$8.9K Buy
821
+56
+7% +$563 ﹤0.01% 1446
2024
Q4
$7.28K Buy
765
+301
+65% +$3.05K ﹤0.01% 1371
2024
Q3
$5.21K Buy
464
+198
+74% +$2.1K ﹤0.01% 1422
2024
Q2
$2.66K Buy
266
+249
+1,465% +$2.53K ﹤0.01% 1502
2024
Q1
$196 Sell
17
-15
-47% -$127 ﹤0.01% 1934
2023
Q4
$234 Sell
32
-79
-71% -$623 ﹤0.01% 1916
2023
Q3
$1.01K Sell
111
-345
-76% -$4.13K ﹤0.01% 1845
2023
Q2
$5.55K Buy
+456
New +$5.08K ﹤0.01% 1326
2023
Q1
Sell
-116
Closed -$2.23K 2013
2022
Q4
$2.23K Buy
116
+108
+1,350% +$2.28K ﹤0.01% 1641
2022
Q3
$0 Buy
+8
New +$164 ﹤0.01% 1784

Other funds holding AHCO

Parkside Financial Bank & Trust's AHCO Position: Q1 2026 in Review

Parkside Financial Bank & Trust reduced its AdaptHealth (AHCO) stake by 0.39% in Q1 2026, selling an estimated $51 and leaving 1,267 shares worth $15.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1425.

Parkside Financial Bank & Trust first reported a position in AHCO in Q3 2022 and has held it in 14 quarters since. 241 funds tracked by Wall St. Rank hold AHCO as of Q1 2026.

  • Parkside Financial Bank & Trust held 1,267 shares of AdaptHealth worth $15.1K as of Q1 2026.
  • Parkside Financial Bank & Trust sold 5 AdaptHealth shares in Q1 2026, an estimated $51.
  • AdaptHealth made up ﹤0.01% of Parkside Financial Bank & Trust's portfolio in Q1 2026, its #1425 holding.
  • Parkside Financial Bank & Trust first reported a position in AdaptHealth in Q3 2022 and has held it in 14 quarters since.
  • 241 funds tracked by Wall St. Rank held AdaptHealth as of Q1 2026.

Based on Parkside Financial Bank & Trust's 13F filing for Q1 2026, filed 13 May 2026.